Spectral AI Completes Pediatric Enrollment for U.S. Burn Pivotal Study
Spectral AI, the developer of the AI-driven DeepView® System, has completed pediatric enrollment for its U.S. Burn Pivotal Study—one of the largest domestic burn studies ever conducted. The study aims to validate the AI-powered algorithm behind DeepView™ for burn assessment, moving the company closer to a De Novo classification submission to the FDA in 2025.
